Angle plc (AGL) Ordinary 10p
0.20p
(0.33%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.20p
(0.33%)
0.20p
(0.33%)
60.00p
60.37p
79.00p
£86.38 million
60.00p
59.40p
38.00p
n/a
1.50p (2.56%) Previous:
1.50p
106,665
n/a
3,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 30/04/2018 | 30/04/2017 |
|---|---|---|
| Revenue (£m) | 0.63 | 0.50 |
| Profit before tax (£m) | (8.93) | (7.41) |
| Adjusted EPS (p): | (10.09) | (8.95) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Open an easy to manage, low cost dealing account in less than 5 minutes
Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.
More about the Fund and Share AccountImportant Documents
There are no documents available for this stock.
Broker forecasts
-
Strong Sell
(0 of 1) -
Sell
(0 of 1) -
Neutral
(1 of 1) -
Buy
(0 of 1) -
Strong Buy
(0 of 1)
This is not a recommendation, it represents the consensus view of a basket of brokers. If fewer than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.
Full broker forecasts-
Angle reveals positive results from latest Parsortix study
31 May 2019 09:53
-
Angle's Parsortix system used in more groundbreaking research
26 April 2019 12:48
-
Angle's Parsortix to be used in new Greece study
12 April 2019 15:25
-
Completion of Ovarian Cancer Pre-Study
5 June 2019 07:00
-
Positive Results from FDA Clinical Study
31 May 2019 07:00
-
IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS
26 April 2019 07:00
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.